Cristina Roca-Oporto

1.8k total citations
27 papers, 291 citations indexed

About

Cristina Roca-Oporto is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Cristina Roca-Oporto has authored 27 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Virology, 11 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Cristina Roca-Oporto's work include HIV Research and Treatment (11 papers), HIV-related health complications and treatments (6 papers) and HIV/AIDS Research and Interventions (5 papers). Cristina Roca-Oporto is often cited by papers focused on HIV Research and Treatment (11 papers), HIV-related health complications and treatments (6 papers) and HIV/AIDS Research and Interventions (5 papers). Cristina Roca-Oporto collaborates with scholars based in Spain, United States and Palestinian Territory. Cristina Roca-Oporto's co-authors include Clara Rosso-Fernández, Elisa Cordero, Francisco López‐Medrano, Patricia Muñóz, Pilar Pérez‐Romero, José Miguel Cisneros, Joan Gavaldà, Teresa Aydillo, José Miguel Cisneros and Jesús Fortün and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Cristina Roca-Oporto

24 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Roca-Oporto Spain 8 138 96 56 54 39 27 291
Cecilia Martín‐Gandul Spain 15 411 3.0× 124 1.3× 52 0.9× 47 0.9× 35 0.9× 19 571
Ferdinando Dodi Italy 9 128 0.9× 74 0.8× 105 1.9× 26 0.5× 53 1.4× 20 313
İlhan Özgüneş Türkiye 9 135 1.0× 98 1.0× 38 0.7× 98 1.8× 17 0.4× 19 309
Cezarina Mindru United States 10 215 1.6× 55 0.6× 103 1.8× 36 0.7× 11 0.3× 16 352
Owen Albin United States 9 89 0.6× 61 0.6× 31 0.6× 40 0.7× 66 1.7× 27 257
Paola Tatarelli Italy 11 119 0.9× 145 1.5× 38 0.7× 22 0.4× 9 0.2× 23 303
C. Flateau France 9 102 0.7× 126 1.3× 43 0.8× 16 0.3× 15 0.4× 30 355
Kenta Ito Japan 11 130 0.9× 65 0.7× 58 1.0× 91 1.7× 22 0.6× 31 329
Mohammad Bosaeed Saudi Arabia 11 158 1.1× 163 1.7× 59 1.1× 59 1.1× 26 0.7× 52 373
Eilish McCann United States 10 129 0.9× 119 1.2× 97 1.7× 79 1.5× 33 0.8× 32 432

Countries citing papers authored by Cristina Roca-Oporto

Since Specialization
Citations

This map shows the geographic impact of Cristina Roca-Oporto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Roca-Oporto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Roca-Oporto more than expected).

Fields of papers citing papers by Cristina Roca-Oporto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Roca-Oporto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Roca-Oporto. The network helps show where Cristina Roca-Oporto may publish in the future.

Co-authorship network of co-authors of Cristina Roca-Oporto

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Roca-Oporto. A scholar is included among the top collaborators of Cristina Roca-Oporto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Roca-Oporto. Cristina Roca-Oporto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiménez‐Sousa, María Ángeles, Javier Martínez‐Picado, Cristina Roca-Oporto, et al.. (2025). Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study. Frontiers in Immunology. 16. 1707510–1707510.
2.
Serna‐Gallego, Ana, María Trujillo‐Rodríguez, Núria Espinosa, et al.. (2024). Plasma concentrations of IL-6, MIP-1β, IP-10, and PTX-3 as predictors of the immunological response to antiretroviral treatment in people with HIV. Frontiers in Immunology. 15. 1447926–1447926. 1 indexed citations
3.
Serna‐Gallego, Ana, María Trujillo‐Rodríguez, Ana Isabel Álvarez‐Ríos, et al.. (2024). Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors. Frontiers in Immunology. 15. 1423734–1423734. 2 indexed citations
4.
Gutiérrez‐Valencia, Alicia, et al.. (2024). Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life. Microbiology Spectrum. 12(8). e0065424–e0065424. 2 indexed citations
5.
Serna‐Gallego, Ana, Luis Eduardo López-Cortés, María Trujillo‐Rodríguez, et al.. (2023). Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV. Journal of Antimicrobial Chemotherapy. 78(9). 2354–2360.
6.
Tarancón‐Díez, Laura, Beatriz Domínguez-Molina, Isabel Gallego, et al.. (2023). Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes. EBioMedicine. 91. 104549–104549. 10 indexed citations
7.
Berenguer, Juan, Inmaculada Jarrín, José M. Bellón, et al.. (2022). Obesity-Related Single-Nucleotide Polymorphisms and Weight Gain Following First-Line Antiretroviral Therapy. Clinical Infectious Diseases. 76(6). 977–985. 5 indexed citations
8.
Trujillo‐Rodríguez, María, Ana Serna‐Gallego, Ezequiel Ruíz-Mateos, et al.. (2022). Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4+ T-cell depletion?. AIDS. 36(9). 1207–1214. 2 indexed citations
9.
Jiménez-Rodríguez, Rosa M., Guillermo Martín-Gutiérrez, Silvia Jiménez‐Jorge, et al.. (2022). Factors associated with recruitment success in the phase 2a study of aztreonam–avibactam development programme: a descriptive qualitative analysis among sites in Spain. BMJ Open. 12(2). e051187–e051187. 2 indexed citations
10.
Trujillo‐Rodríguez, María, Ana Serna‐Gallego, Juan Manuel Praena‐Fernández, et al.. (2022). Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial. Clinical Microbiology and Infection. 28(8). 1151.e9–1151.e16. 12 indexed citations
11.
Asensio-Cruz, María Isabel, José Manuel Lomas, Cristina Roca-Oporto, et al.. (2021). Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before–After Study (CortiCOVID Study). SHILAP Revista de lepidopterología. 3(2). 100086–100086. 3 indexed citations
12.
Guisado-Gil, Ana Belén, Carmen Infante-Domínguez, Germán Peñalva, et al.. (2020). Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections. Antibiotics. 9(11). 816–816. 40 indexed citations
13.
Vitallé, Joana, Laura Tarancón‐Díez, Iñigo Terrén, et al.. (2020). CD300a identifies a CD4+ memory T cell subset with a higher susceptibility to HIV-1 infection. AIDS. 34(8). 1249–1252. 1 indexed citations
14.
Aydillo, Teresa, Alba Escalera, Shirin Strohmeier, et al.. (2020). Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients. Cell Reports Medicine. 1(8). 100130–100130. 21 indexed citations
15.
Cisneros, José Miguel, Clara Rosso-Fernández, Cristina Roca-Oporto, et al.. (2019). Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial. Critical Care. 23(1). 383–383. 56 indexed citations
16.
Roca-Oporto, Cristina, Younes Smani, F.M. González-Roncero, et al.. (2019). Prevalence and clinical impact of Streptococcus pneumoniae nasopharyngeal carriage in solid organ transplant recipients. BMC Infectious Diseases. 19(1). 697–697. 7 indexed citations
17.
Cordero, Elisa, Cristina Roca-Oporto, Ángel Bulnes‐Ramos, et al.. (2017). Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1–2, a Randomized Controlled Clinical Trial. Clinical Infectious Diseases. 64(7). 829–838. 74 indexed citations
18.
Martínez‐Atienza, Juliana, Clara Rosso-Fernández, Cristina Roca-Oporto, et al.. (2014). Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial. Trials. 15(1). 338–338. 3 indexed citations
19.
Roca-Oporto, Cristina, et al.. (2012). Monitoring the Natural Evolution and Response to Treatment of Post Liver Transplant Recurrent Hepatitis C Using Transient Elastography: Preliminary Results. Transplantation Proceedings. 44(7). 2082–2086. 5 indexed citations
20.
Múñoz, Juan José, Cristina Roca-Oporto, José Luis Santos, Miguel A. Arroyo, & Rafael Enrı́quez de Salamanca. (1993). Effect of Zinc or S‐Adenosyl‐l‐methionine on Long Term Administration of Low Doses of Lead to Rats. Pharmacology & Toxicology. 73(4). 189–191. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026